TASL and neoplasm: As an adaptor for TLR7-9 signaling, the TASL-SLC15A4 complex specifically activates the transcription factor IRF5 [23], which in turn induced the release of proinflammatory cytokines, chemokines, and IFNs [34], the latter of which can play an integral role in tumorigenesis and tumor progression.